BioCentury | Jul 30, 2020
Deals

F-Star lands on NASDAQ sooner than expected via reverse merger

...Programmed cell death 1 ligand 1 STING (TMEM173) - Transmembrane protein 173 Stephen Hansen, Associate Editor F-star Biotechnology Ltd. Spring...
BioCentury | May 30, 2020
Tools & Techniques

Denali offers rare peek into the science behind its CNS delivery platform

...Protein engineering The idea behind Denali’s TV platform originated from an antibody-engineering technology developed at F-star Biotechnology Ltd....
BioCentury | Apr 25, 2020
Translation in Brief

Molecular Partners’ trifunctional COVID-19 therapeutic; plus F-star, Inscopix and Ocean Biomedical

...The company expects to produce a GMP compliant compound in 3Q20. F-star’s bispecific checkpoint inhibitor F-star Biotechnology Ltd....
...glutamic acid-rich protein ( P. falciparum GARP) SARS-CoV-2 S - SARS-CoV-2 spike protein BioCentury Staff FS118 Molecular Partners AG F-star Biotechnology Ltd. Programmed...
BioCentury | Mar 12, 2020
Management Tracks

Hoerr takes helm from Menichella at CureVac; plus Genmab hires Mancini as COO, Tricida, Akcea, Refuge, Adaptate, Thermo Fisher and more

...of hires Tuesday, including Mihriban Tuna as CSO. She was SVP of drug discovery at F-star Biotechnology Ltd....
BioCentury | Nov 27, 2019
Company News

Management tracks: Ultragenyx COO to step down next year; plus Agios, MiMedx, Iveric, Ardelyx, Novo Seeds, Axcella, NervGen

...down as CEO of Vaccibody A/S in September; John Haurum, who served as CEO of F-star Biotechnology Ltd....
BioCentury | Jun 19, 2019
Company News

Management tracks: Ultragenyx promotes Erik Harris; plus F-star, Arbutus, Maze and more

...and chief commercial officer from SVP, head of North American commercial operations. Bispecific antibody company F-star Biotechnology...
...Diagnostics and is president of American Association for Clinical Chemistry. Jonathan Block, Associate Editor Arbutus Biopharma Arbutus Biopharma Corp. F-star Biotechnology F-star Biotechnology Ltd. Maze...
BioCentury | Jun 11, 2019
Company News

Management Tracks: Agios’ Biller to retire as CSO; plus Vectura, Molecular Partners, F-star and more

...company. SVP of Research Daniel Steiner will lead Molecular Partners’ research team. Bispecific antibody company F-star Biotechnology Ltd....
...Ltd. (Beersheba, Israel), both of which he co-founded. BioCentury Staff Agios Pharmaceuticals Inc. Biophytis S.A. Celsius Therapeutics eGenesis Inc. EyePoint Pharmaceuticals Inc. F-star Biotechnology Ltd. Medicure...
BioCentury | Jun 1, 2019
Product Development

ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts

...efficacy. Other companies presenting dual checkpoint bispecifics at ASCO include MacroGenics Inc., Alligator Biosciences AB, F-Star Biotechnology Ltd....
...Shanghai, China Chinese PLA General Hospital, Beijing, China Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. F-star Biotechnology Ltd....
...Hematology Amgen Inc. Baylor College of Medicine Bellicum Pharmaceuticals Inc. CARsgen Therapeutics Co. Ltd. Chinese PLA General Hospital Eli Lilly and Co. F-star Biotechnology Ltd. Huazhong...
BioCentury | May 14, 2019
Company News

May 14 Company Quick Takes: F-star rejiggers Merck KGaA deal; plus Roche/Spark, AbbVie/Boehringer, Ipsen

...F-star to keep lead bispecific in new deal with Merck KGaA F-star Biotechnology Ltd. (Cambridge, U.K.) reconfigured its...
...PDUFA date is Nov. 9. Elizabeth S. Eaton, Staff Writer FS118 Humira, adalimumab (D2E7) Tlando, testosterone undecanoate (LPCN 1021) AbbVie Inc. F-star Biotechnology Ltd. Ipsen...
BioCentury | Apr 3, 2019
Financial News

AgomAb emerges from stealth with €21M series A

...and chief development officer at argenx S.E. (Euronext:ARGX; NASDAQ:ARGX). John Haurum, most recently CEO of F-star Biotechnology Ltd....
Items per page:
1 - 10 of 50
BioCentury | Jul 30, 2020
Deals

F-Star lands on NASDAQ sooner than expected via reverse merger

...Programmed cell death 1 ligand 1 STING (TMEM173) - Transmembrane protein 173 Stephen Hansen, Associate Editor F-star Biotechnology Ltd. Spring...
BioCentury | May 30, 2020
Tools & Techniques

Denali offers rare peek into the science behind its CNS delivery platform

...Protein engineering The idea behind Denali’s TV platform originated from an antibody-engineering technology developed at F-star Biotechnology Ltd....
BioCentury | Apr 25, 2020
Translation in Brief

Molecular Partners’ trifunctional COVID-19 therapeutic; plus F-star, Inscopix and Ocean Biomedical

...The company expects to produce a GMP compliant compound in 3Q20. F-star’s bispecific checkpoint inhibitor F-star Biotechnology Ltd....
...glutamic acid-rich protein ( P. falciparum GARP) SARS-CoV-2 S - SARS-CoV-2 spike protein BioCentury Staff FS118 Molecular Partners AG F-star Biotechnology Ltd. Programmed...
BioCentury | Mar 12, 2020
Management Tracks

Hoerr takes helm from Menichella at CureVac; plus Genmab hires Mancini as COO, Tricida, Akcea, Refuge, Adaptate, Thermo Fisher and more

...of hires Tuesday, including Mihriban Tuna as CSO. She was SVP of drug discovery at F-star Biotechnology Ltd....
BioCentury | Nov 27, 2019
Company News

Management tracks: Ultragenyx COO to step down next year; plus Agios, MiMedx, Iveric, Ardelyx, Novo Seeds, Axcella, NervGen

...down as CEO of Vaccibody A/S in September; John Haurum, who served as CEO of F-star Biotechnology Ltd....
BioCentury | Jun 19, 2019
Company News

Management tracks: Ultragenyx promotes Erik Harris; plus F-star, Arbutus, Maze and more

...and chief commercial officer from SVP, head of North American commercial operations. Bispecific antibody company F-star Biotechnology...
...Diagnostics and is president of American Association for Clinical Chemistry. Jonathan Block, Associate Editor Arbutus Biopharma Arbutus Biopharma Corp. F-star Biotechnology F-star Biotechnology Ltd. Maze...
BioCentury | Jun 11, 2019
Company News

Management Tracks: Agios’ Biller to retire as CSO; plus Vectura, Molecular Partners, F-star and more

...company. SVP of Research Daniel Steiner will lead Molecular Partners’ research team. Bispecific antibody company F-star Biotechnology Ltd....
...Ltd. (Beersheba, Israel), both of which he co-founded. BioCentury Staff Agios Pharmaceuticals Inc. Biophytis S.A. Celsius Therapeutics eGenesis Inc. EyePoint Pharmaceuticals Inc. F-star Biotechnology Ltd. Medicure...
BioCentury | Jun 1, 2019
Product Development

ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts

...efficacy. Other companies presenting dual checkpoint bispecifics at ASCO include MacroGenics Inc., Alligator Biosciences AB, F-Star Biotechnology Ltd....
...Shanghai, China Chinese PLA General Hospital, Beijing, China Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. F-star Biotechnology Ltd....
...Hematology Amgen Inc. Baylor College of Medicine Bellicum Pharmaceuticals Inc. CARsgen Therapeutics Co. Ltd. Chinese PLA General Hospital Eli Lilly and Co. F-star Biotechnology Ltd. Huazhong...
BioCentury | May 14, 2019
Company News

May 14 Company Quick Takes: F-star rejiggers Merck KGaA deal; plus Roche/Spark, AbbVie/Boehringer, Ipsen

...F-star to keep lead bispecific in new deal with Merck KGaA F-star Biotechnology Ltd. (Cambridge, U.K.) reconfigured its...
...PDUFA date is Nov. 9. Elizabeth S. Eaton, Staff Writer FS118 Humira, adalimumab (D2E7) Tlando, testosterone undecanoate (LPCN 1021) AbbVie Inc. F-star Biotechnology Ltd. Ipsen...
BioCentury | Apr 3, 2019
Financial News

AgomAb emerges from stealth with €21M series A

...and chief development officer at argenx S.E. (Euronext:ARGX; NASDAQ:ARGX). John Haurum, most recently CEO of F-star Biotechnology Ltd....
Items per page:
1 - 10 of 50